Notable Call Buying Activity in Teva Pharma (TEVA) Continues -Susquehanna
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $36.76 +1.10%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.4%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.4%
Join SI Premium – FREE
Susquehanna options strategist Alison Edwards notes continued buying activity Teva Pharma (NYSE: TEVA) , as an opening investor bought 15k Jan 15 Calls, most for $1.10, creating ~750k shares to buy.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Explosions heard on Iran's Kharg island - MEHR
- FDA set to permanently fill top drug, vaccine, and tobacco roles - Bloomberg
- Google and Blackstone data-center venture hits delays at key sites - Bloomberg
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
